This trial is active, not recruiting.

Condition rheumatoid arthritis
Sponsor University of Oxford
Collaborator UCB Pharma
Start date October 2012
End date December 2016
Trial size 220 participants
Trial identifier NCT01707186, 2010930


PRISM (Pictorial Representation of Illness and Self Measure) has been developed since the mid-1990s; the task was first developed as a simple measure of how a person was coping with his or her experience of illness. This is an international, multicentre study to evaluate the PRISM tool for the assessment of suffering in rheumatoid arthritis at different stages of the illness and the effect of treatment intervention. There are 5 sites: Berlin, Oxford, Limoges, Montreal and Queensland. The study will recruit 200 patients in total.

In addition to the procedures for the patient's routine clinical visit, the patients will be invited to answer a series of questionnaires and donate 20ml blood sample. Patients will be asked to attend 3 times over 24 weeks

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective
Early phase, requiring change in treatment
Established phase, stable treatment
Established phase, requiring a change in treatment
Early phase, stable treatment

Primary Outcomes

time frame: 30 September 2015

Eligibility Criteria

Male or female participants from 18 years up to 90 years old.

Inclusion Criteria: - Participant is willing and able to give informed consent for participation in the study. - Male or Female, aged 18 years or above. - Written confirmed diagnosed of rheumatoid arthritis Exclusion Criteria: - A diagnosis of any of the following: - Multiple sclerosis - Motor neurone disease - Parkinson's disease - Alzheimer's disease - Depression or anxiety disorders as identified using the Patient depression screening questions from the patient health questionnaire 9 (PHQ9).

Additional Information

Official title Pictorial Representation of Illness and Self Measure
Principal investigator Peter Taylor, FRCP, PhD
Trial information was received from ClinicalTrials.gov and was last updated in May 2016.
Information provided to ClinicalTrials.gov by University of Oxford.